Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
8 patents granted to the 2 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Entera Bio Ltd.’s names, not what it holds today.
Patents granted
8
8 utility, 1976 to Dec 31, 2025
Granted in 2025
2
Against 1 in 2024 and none in 2023
Applications published
19
5 of them in 2025
Names they are printed under
2
its own name
By yearGrantedApplications published
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name2 counted
Entera Bio Ltd. its own name
IL, as the owner printed on each patent
8 granted
16 publishedEntera Bio Ltd. its own name
named as the applicant on its applications, in IL
0 granted
3 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| May 27, 2025 | 12,311,051 | Methods and compositions for oral administration | Pharmaceuticals | Entera Bio Ltd. |
| Mar 4, 2025 | 12,239,691 | Formulations for oral administration of active agents | Pharmaceuticals | Entera Bio Ltd. |
| Sep 3, 2024 | 12,076,373 | Formulations for oral administration of active agents | Pharmaceuticals | Entera Bio Ltd. |
| Feb 15, 2022 | 11,246,827 | Methods and compositions for oral administration | Pharmaceuticals | Entera Bio Ltd. |
| Mar 10, 2020 | 10,583,177 | Formulations for oral administration of active agents | Pharmaceuticals | Entera Bio Ltd. |
| Sep 24, 2019 | 10,420,721 | Methods and compositions for oral administration | Pharmaceuticals | Entera Bio Ltd. |
| Jul 3, 2018 | 10,010,503 | Methods and compositions for oral administration | Pharmaceuticals | Entera Bio Ltd. |
| Nov 17, 2015 | 9,186,412 | Methods and compositions for oral administration of insulin | Pharmaceuticals | Entera Bio Ltd. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Sep 11, 2025 | 2025/0281396 | METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION | Pharmaceuticals | Entera Bio Ltd. |
| Jun 12, 2025 | 2025/0186559 | FORMULATIONS COMPRISING ACID-NEUTRALIZING POLYMER FOR ORAL ADMINISTRATION OF PARATHYROID HORMONE | Pharmaceuticals | Entera Bio Ltd. |
| Jun 12, 2025 | 2025/0186558 | FORMULATIONS COMPRISING ACID-NEUTRALIZING POLYMER FOR ORAL ADMINISTRATION OF ACTIVE AGENTS | Pharmaceuticals | Entera Bio Ltd. |
| Jun 12, 2025 | 2025/0186555 | FORMULATIONS COMPRISING ACID-NEUTRALIZING POLYMER FOR ORAL ADMINISTRATION OF GLUCAGON-LIKE PEPTIDE-2 | Pharmaceuticals | Entera Bio Ltd. |
| Jun 12, 2025 | 2025/0186554 | FORMULATIONS COMPRISING ACID-NEUTRALIZING POLYMER FOR ORAL ADMINISTRATION OF GLUCAGON-LIKE PEPTIDE-1 AND ANALOGS THEREOF | Pharmaceuticals | Entera Bio Ltd. |
| Dec 19, 2024 | 2024/0415936 | FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS | Pharmaceuticals | Entera Bio Ltd. |
| Dec 5, 2024 | 2024/0398904 | FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS | Pharmaceuticals | Entera Bio Ltd. |
| Jun 6, 2024 | 2024/0181020 | TREATMENT OF HYPOPARATHYROIDISM | Pharmaceuticals | Entera Bio Ltd. |
| May 19, 2022 | 2022/0151919 | METHODS AND COMPOSITIONS FOR ORAL ADMINISTRATION | Pharmaceuticals | Entera Bio Ltd. · patent 12,311,051 granted from it |
| May 7, 2020 | 2020/0138913 | FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS | Pharmaceuticals | Entera Bio Ltd. · patent 12,076,373 granted from it |
What it applied for, 2024 to 2025: Pharmaceuticals 8.
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.